TNYA Projected Dividend Yield
Tenaya Therapeutics Inc ( NASDAQ : TNYA )Tenaya Therapeutics, Inc. is a clinical-stage biotechnology company. Co. is focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. Co. is advancing a pipeline of novel therapies with diverse treatment modalities for rare genetic cardiovascular disorders and more prevalent heart conditions. Co.'s advanced product candidates include TN-201, TN-401, and TN-301. TN-201 is an adeno-associated virus serotype 9 (AAV9)-based gene therapy being developed to treat the underlying cause of MYBPC3 associated HCM by delivering a working MYBPC3 gene to specific cells of the heart via a single infusion. 21 YEAR PERFORMANCE RESULTS |
TNYA Dividend History Detail TNYA Dividend News TNYA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |